Plunkett Research Online: Edesa Biotech Inc

EDESA BIOTECH INC (EDSA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Edesa Biotech Inc is a biopharmaceutical company focused on acquiring, developing and commercializing clinical-stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. Its lead product candidate, EB01, is an sPLA2 inhibitor for the topical treatment of chronic .....



Edesa Biotech Inc
Ticker: EDSA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 905 475-1234
Fax:
Address: 100 Spy Court
Markham, ON L3R 5H6 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Biotechnology
ContactsDescription

Pardeep NijhawanCEO/Director
Kathi NiffeneggerCFO
See More
Edesa Biotech Inc is a biopharmaceutical company focused on acquiring, developing and commercializing clinical-stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. Its lead product candidate, EB01, is an sPLA2 inhibitor for the topical treatment of chronic .....See More See More

Auditor: MNP LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: